Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.

This study has been terminated.

( Loss of funding )

Study NCT00364364 Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received: August 14, 2006 Last Updated: December 16, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	June 2008
Estimated Primary Completion Date:	No date given